Verteporfin is a substrate-selective γ-secretase inhibitor that binds the amyloid precursor protein transmembrane domain is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: 0922862
MRI: Acquisition of a 900 MHz Ultra-High Field NMR Spectrometer
National Science Foundation
Grant: DGE-1445197
National Institutes of Health
Grant: RF1 AG056147
National Institutes of Health
Grant: R01 GM122894
NIGMS NIH HHS
Grant: R01 GM138620
NCRR NIH HHS
Grant: S10 RR025677
NIGMS NIH HHS
Grant: T32 GM008320
NIA NIH HHS
Grant: F31 AG069462
National Institutes of Health
Grant: 5R01GM122894-02
Mechanisms of Gamma-Secretase
National Science Foundation
Grant: 1445197
Graduate Research Fellowship Program (GRFP)
National Institutes of Health
Grant: 1RF1AG056147-01
Roles of Cholesterol and Membrane Nanodomains in the Amyloidogenic Pathway
National Institutes of Health
Grant: 1S10RR025677-01
Console upgrades for biological NMR spectrometers
National Institutes of Health
Grant: 1F31AG069462-01
Discovery of small molecules that specifically target the transmembrane C99 domain of the Amyloid Precursor Protein.
Vanderbilt University
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals